Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVE: Metronomic Oral Vinorelbine in Advanced NSCLC
2010-018762-23Phase 2Active
- Sponsor
- Azienda Unità Sanitaria Locale 12 di Viareggio
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in non-small cell lung cancer (NSCLC) and Non-small cell lung cancer adenocarcinoma (NSCLC), sponsored by Azienda Unità Sanitaria Locale 12 di Viareggio. Primary endpoints: Overall response rate (ORR) and Clinical benefit (CB). Started May 2010; status: active.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)Non-small cell lung cancer adenocarcinoma (NSCLC)
Beyond the preview
Go deeper on 2010-018762-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018762-23.